Abstract
The failures of glutaraldehyde (GLUT) cross‐linked bioprosthetic heart valves (BHVs) are mainly due to degeneration and calcification. In this study, we developed a new preparation strategy for BHVs named as “HPA/EDC/EGCG” that utilized 3,4‐hydroxyphenylpropionic acid (HPA)‐conjugated pericardium, epigallocatechin gallate (EGCG), and horseradish peroxidase (HRP)/hydrogen peroxide (H2O2) enzymatic cross‐linking. HPA–pericardium conjugation was done by carbodiimide coupling reaction using 1‐ethyl‐3‐(3‐dimethylaminopropyl) carbodiimide (EDC) and N‐hydroxysuccinimide (NHS). Then HPA‐conjugated pericardium was cross‐linked by HRP/H2O2 enzyme‐catalyzed oxidation. The feeding ratios of HPA and EGCG were optimized. The consumption of amino groups, collagenase and elastase degradation in vitro, biomechanics, extracellular matrix stability, and calcification of HPA‐/EDC‐/EGCG‐treated pericardiums were characterized. We demonstrated that HPA‐/EDC‐/EGCG‐treated pericardiums had better elastin stabilization and less calcification. EGCG and enzymatic cross‐linking treated pericardiums showed improved mechanical properties. This new EGCG and enzymatic cross‐linking strategy would be a promising method to make BHVs with better elastin stability and anti‐calcification property. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 107B: 1551–1559, 2019.
Funding Information
  • National Natural Science Foundation of China (31700833)

This publication has 29 references indexed in Scilit: